A silencing element has been previously located upstream of the human e-globln gene promoter using transient assays and transgenic mice carrying plasmid constructs In which the element has been deleted or its transcriptional motifs have been mutated. To Investigate whether this element functions in the context of the whole p-globln locus, we analyzed e-globin gene expression in transgenic mice carrying a deletion of the silencing element in the context of a 213·kllobase human p-globin yeast artificial chromosome (P-YAC). e-Globin gene expression was measured during embryonic and fetal development and in adult mice. e-mRNAlevels in embryonic cells in Day 12 blood were as high as those measured In Wild-type p·YAC controls, Indicating that the deletion does not affect e gene promoter function. e-Globin gene expression was confined to the embryonic cells, Indicating that deletion of this silencing element did not affect e-globln developmental expression in the context of the p-YAC. These results suggest that in the context of the whole p-globin locus, other proximal and upstream t gene promoter elements as well as competition by the downstream globin genes contribute to the silencing of the e-globln gene in the cells of definitive erythropoiesis. Exp Bioi Med 231 : [328][329][330][331][332][333][334] 2006 
Introduction
Switches of gene expression during development are characteristic of the globin genes of all species that use 328 hemoglobin for oxygen transport. These switches are controlled by proximal as well as by distal regulatory elements. The major distal regulatory element is the locus control region (LCR) located 6-22 kilobases (kb) upstream of the~-globin gene cluster. This powerful element is comprised of five developmentally stable DNase I-hypersensitive sites (HS I-HS5) (1-4), it is necessary for enhancing globin gene expression (3, 5, 6) , and it is involved in the developmental control of the globin genes (7, 8) . The proximal regulatory elements controlling y and~gene expression are located predominantly in the promoters of the y and~.genes (9) (10) (11) (12) . Proximal silencing elements have also been identified in the promoter of the human embryonic s-globin gene (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) . Thus, transgenic mice carrying a construct consisting of a 3.7-kb human E gene sequence containing a 2-kb promoter linked to a 2.5-kb microlocus control region (IlLCR) fail to express the Egene in the adult stage of development (19) . These results indicated that all elements involved in developmental regulation of the embryonic gene are located in the 3.7-kb Egenomic sequence contained in the transgenic construct. Subsequent studies showed that deletion of a 285-base-pair (bp) sequence (from -182 to -467) from the 2.0-kb s-globin gene promoter resulted in s-globin gene expression in the adult stage of development (13) , providing in vivo evidence that this sequence contains a silencer. Other transgenic mouse studies have identified negative regulatory sequences between 2000 bp and 463 bp upstream of the s-globin gene cap site (20) . Silencing elements are also located in the direct repeats (DR) adjacent to the s-globin gene CCAAT box (21, 22) .
In the present study, we investigated the functional role of the E gene silencer in the context of a 213-kb~human globin locus YAC (~-YAC). We deleted this element from the E gene of~-YAC and examined globin gene expression. in transgenic mice carrying the mutant YAC (L\E Sil~-YAC). The L\E sil~-YAC transgenic lines showed normal a-globin gene expression in embryonic cells, but in contrast to the results obtained with the IlLCRE transgenic constructs mentioned previously, E gene expression was silenced in the fetal and adult erythroid cells of definitive erythropoiesis. These results suggest that in the context of an intact -globin locus, other cis elements of the proximal and the distal e gene promoter, together with competition by the downstream globin genes, are sufficient to downregulate e-globin gene expression in definitive erythropoiesis. YAC Purification and Production of Transgenic Mice. The yeast strain containing the Ae sil~-YAC was grown and isolated as previously described (8) . The purified and filtered YAC was injected into fertilized mouse eggs (B6/ C3Fl) and then transferred to pseudopregnant foster mothers (B6/D2Fl). Transgenic founder animals were identified by Southern hybridization slot blot of tail DNA. The transgenic founders were bred with nontransgenic mice (B6/D2Fl) to produce F1 progeny, and the F1 males were subsequently bred for staged pregnancies that were interrupted at postconception Days -10, -12, and -14 and to produce F 2 adults.
Materials and Methods

Construction of the
Determination of Transgene Copy Number. For
the Ae sil~-YAC transgenic lines, agarose plugs containing high-molecular-weight liver DNA was digested with restriction enzymes overnight,' and the resultant fragments were fractionated by agarose gel electrophoresis and blotted onto zeta-probe positive charged nylon membrane (Bio-Rad, Hercules, CA). Transgene copy number was determined by comparing HS4, HS3, HS2, e-, A y_, and~-globin gene hybridization signals to the endogenous murine Thy 1.1 signals by Southern blot hybridization analyses as previously described (8, 24) . The radioactive signals were measured using a PhosphorImager (Molecular Dynamics, Sunnyvale, CA), and the ratios of human globin sequences to Thy l.I (corrected for a haploid genome) were calculated to determine transgene copy number.
Structural Analysis of As slI p-YAC Transgenic
Mice. High-molecular-weight DNA embedded in agarose was prepared as previously described (24) . The 32 p _ radiolabeled probes used in the Southern hybridization analyses for the structural analyses are as follows: 0.7-kb Pstl HS3, 1.9-kb HindIII HS2, 1.8-kb Xbal HS1, 3.7-kb EcoRI a-globin gene, 2.4-kb EcoRI fragment 3' of the A y_ globin gene, 1.0-kb EcoRV \jJ~region, 2.1-kb PstI fragment upstream of the a-globin gene, 0.9-kb EcoRI-BamHI fragment 3' of the~-globin gene, 1.4-kb Xbal DFlO (3'HS1), 1.9-kb Bgffi HPFH3, 0.5-kb HindIII H500, and 1.5-kb EcoRI-Bgffi HPFH6.
Measurement of Globin mRNA Synthesis. Total RNA was isolated from yolk sac, fetal liver, and blood from F 2 transgenic embryos, fetuses, and adults using the RNAgents total RNA Isolation System following the manufacturer's instructions (Promega, Madison, WI). Human and murine globin mRNAs were detected by RNase protection analysis and the signals quantified using a PhosphorImager (Molecular Dynamics). Template DNAs used to prepare riboprobes to measure human e-, y-, and~-globin mRNA were pTIHue(188), pTI A yffi(170), and pT7~ffi, respectively, and to measure endogenous murine ex-and~-globin, we used plasmids pTI Moo and pT7 Mo~, respectively. The source. and amount (in parentheses) of isolated RNAs used in RNase protection assays are as follows: Day 10 yolk sac (1000 ng), Day 12 liver (500 ng), Day 12 blood (80 ng), Day 14 liver (500 ng), and adult blood (50 ng).
Polymerase Chain Reactions. The 5' flanking region of the e-globin gene was amplified using the following e-globin specific primers: LlE#3 (proximal) 5' GGCTICTCAGCTCCCTICCCAGTG 3' and LlE#4 (distal) 5' GTCAGGTCCGGAGAGGGTCAGC 3'. One hundred nanograms of genomic DNA were PCR amplified using Taq DNA polymerase in Storage Buffer B following the manufacturer's instructions (Promega). The PCR conditions were the following: 30 sees at 95°C, 45 sees at 58°C, 40 sees at noc for 30 cycles.
Results
Production of Llf: sll p-YAC Transgenic Mice. To examine the effects of deletion of the s-globin gene silencer in the context of the whole human~-globin locus, a 224-bp'
HindU-BamHI fragment encompassing the -406-to -182bp region upstream of the s-globin cap site was deleted from a 213-kb~-YAC harboring the human~-globin locus (25) (Fig. 1 ). The deletion of this element was done by homologous recombination of a mutant s-promoter sequence following transformation of a yeast strain containing a wild-type 213-kb~-YAC (26) . The resulting mutant LlE sil -YAC was purified and microinjected into pronuclei of fertilized mouse oocytes. An assessment of transgene integration and globin gene expression was done in F2 progeny of transgenic mouse lines.
Confirmation of the Deletion of the E-Gene
Silencer in LiE slI p-YAC Transgenic Mice. Three LlE sil -YAC transgenic lines A, B, and C were established, and the deletion of the 224-bp fragment was confirmed by polymerase chain reaction (PCR) assay. To confirm the size of the deletion, we designed two oligonucleotides that PCR amplify the region upstream of the minimal e-globin promoter. In the wild-type~-globin locus, the two primers are located at position -824 and -150 relative to the start of transcription, resulting in a 674-bp PCR amplicon ( Fig. 2A , top panel). Because of the 224-bp deletion of the a-silencer element, the PCR reaction performed on DNA isolated from LlE sH~-YAC transgenic lines results in a 450-bp amplicon-Notice in Figure 2A that the agarose gel shows only the 450-bp fragment in each of the three mutant f3-YAC lines A, B, and C, while the 674-bp fragment was amplified from DNA isolated from the wild-type f3-YAC (lane w"), These fragments were sequenced to ensure that no other mutations were introduced (data not shown).
Structural Analysis of At s ll~-YAC Transgenic Lines. Most of the~-globin locus of the Ae sil~-YAC is contained on a 115-kb SftI restriction enzyme fragment, having a 5' boundary between HS3 and HS4 of the LCR and . a 3' boundary downstream of the hereditary persistence of fetal hemoglobin (HPFH) 6 breakpoint, approximately 60 kb downstream of the~-globin gene. To examine the structural integrity of the individual YACs integrated into the murine genome,~-YAC trangenic mouse DNA embedded in agarose was digested with SftI, and the DNA fragments were fractionated by pulsed-field gel electrophoresis and subjected to Southern hybridization analysis. The integrity of an individual~-YAC copy was determined by the hybridization of a series of probes that reside along the~ globin locus. Presence of these hybridization fragments determines the continuity of the globin locus sequences. The 12 probes used to determine~-YAC intactness are listed in Materials and Methods and are shown on the schematic drawing of the~-globin locus in Figure 2B . Line A has two SftI fragments: an intact 115-kb SftI fragment containing two copies of the~-globin locus from the HS3 of the LCR to the HPFH3 breakpoint and a 150-kb fragment containing portion of the~-globin cluster but missing the LC;:R; because of the deletion of the LCR, this 150-kb fragment is not expected to contribute to the globin gene expression.
Lines B and C have a single intact 115-kb~-YAC. Copy number analysis determined that these transgenic lines contain a single copy of the Ae sil~-YAC.
Analysis of t-Globln Gene Expression
In At 811 -YAC Transgenic Mice. To determine the contribution of the s-gene silencer on the temporal regulation of the human globin genes in the context of the intact~-globin locus, we measured the expression of human globin genes as well the endogenous murine tJ.-and~-globin genes by RNase protection analysis. The amount of human messenger RNA was measured by phosphorimaging analysis, and the expression levels were calculated as a percentage of endogenous murine ex +~globin per gene copy.
To assess globin gene expression during development, we isolated total RNA from yolk sac, liver, and blood samples Fig. 3 and Table   1 ).
The definitive stage of erythropoiesis begins in the murine fetal liver on Day 10.5 and is characterized by exclusive transcription the adult globin genes,~-major and -minor. In the wild~-YAC fetuses, mean e expression in the Day 12 fetal liver was 1.9 ± 0.7%; as previously shown (8) , these amounts of e mRNA are contributed by primitive erythroblasts and nucleated erythrocytes of yolk sac origin that contaminate the fetal liver. By Day 14, s-globin mRNA transcript is undetectable in the wild~-YAC mice by RNase protection (Fig. 3 and Table 1 ). The mean level e mRNA among the .1e sil~-YAC lines was 1.2% ± 0.8% in Day 12 fetal liver, and by Day 14, s expression was undetectable.
To confirm that the e mRNA detected in the Day 12 .1e sil~ YAC lines was due to contaminating embryonic erythroblasts, we stained the fetal liver preparations with anti-eglobin monoclonal antibodies; only embryonic erythroblasts characterized by their large cytoplasmic/nucleus volume ratio and their pycnotic nucleus stained positive (data not shown). We therefore conclude that despite the absence of the -406 to -182 sequence, there was no detectable s-globin gene expression by the erythroid cells of the definitive erythropoiesis of the fetal liver of the .1e sil~-YAC lines.
Analysis of y and PGene Expression in the M: s Jl p-YAC Mice. In wild-type~-YAC mice, humanẽ xpression is restricted to cells of definitive erythropoiesis, while human y-globin gene expression occurs during the embryonic erythopoiesis of the yolk sac as well as during the definitive erythropoiesis of the fetal liver. y-Globin gene expression in the .1e sil~-YAC ranged from 11.7%-13.2% (mean 12.6% ± 0.8%) in Day 10 yolk sac and from 20.2%-21.3% (mean 21.8% ± 2.1%) in Day 12 blood; these values are statistically indistinguishable from those of the wild-type control ( Fig. 3 and Table 2 ). During definitive erythropoiesis, y-and~-globin gene expression levels in .1e sil~-YAC transgenic mice were similar to those measured in the wild-type controls ( Fig. 3 and Table 2 ). The mean y-globin mRNA levels in Day 12
and Day 14 fetal liver were 12.0% ± 4.4% and 2.9% ± 1.9%, respectively. A modest decline of 1.5-fold and 1.3fold in Day 12 and Day 14 fetal liver, respectively, was statistically insignificant compared to the wild-type controls. The mean~-globin mRNA level during definitive erythropoiesis was 40.7% ± 10.9%,49.8% ± 15.8%, and 87.5% ± 22.2% at Fetal Days 12 and 14 and in the adult stage of development, respectively. We conclude that the 224-bp deletion upstream of the s-globin minimal promoter did not affect gene expression of the downstream y-and~-globin genes during definitive erythropoiesis.
Discussion
Two regulatory components are required for proper human embryonic s-globin gene expression in transgenic mice: the LCR and the s-globin promoter. Previous studies have demonstrated that DNA sequences upstream of the s-globin gene promoter contribute to silencing of e-globin gene expression in definitive cells of the fetal liver (13, 18, 19) . A small transgenic construct consisting of 2.5-kb micro-LCR (J-lLCR) linked to the s-globin gene resulted in e gene expression in primitive erythroblasts of yolk sac origin but failed to express in the cells of the definitive erythropoiesis of the fetal liver or adult bone marrow (19) . The simplest and most probable explanation for this observation is that ciselements located upstream of the s-globin gene are responsible for the confinement of s-globin gene expression to embryonic erythropoiesis. Studies in transgenic mice have identified multiple elements involved in gene silencing that are located botli'proximally and distally to the s-globin gene promoter (13, (20) (21) (22) . Deletion of 285 bp, from -467 to -182, of the e gene promoter affects developmental silencing, resulting in continuation of e gene expression in adult erythropoiesis (13) . This -467 to -182 e sequence contains three GATA sites in positions -208, -267, and -278, one YYl site in position -269, and one SPI site in position -379.
Ina previous study (28) , these sites were mutated individually and in combination to abolish protein binding, and transgenic mice were produced after linking the mutated e genes with a 2.5-kb IlLCR cassette. Mutation of either the YYl site in position -269 or of the GATA site in position -208 resulted in continuation of e gene expression in the adult erythropoiesis (28) . In contrast, mutation of the two tandemly placed GATA-I sites in positions -267 and -278 either individually or in combination failed to affect s gene silencing. These results suggested that the silencing of the e gene is combinatorial and predicted that more than one DNA binding protein participates in the formation of the silencing complex.
Inthe present study, deletion of a 224-bp sequence containing all the known motifs of the a-globin gene silencer region from the 213-kb~-YAC did not affect s gene silencing in primitive erythroblasts, but e gene expression was not detectable in the cells of definitive erythropoiesis of fetal liver. How can we reconcile the different phenotypes obtained when the silencer is deleted in the context of the 2.5-kb IlLCR::e gene construct Versus the 213-kb~locus YAC?
First, the deletion of the silencer element done in the Context of the~-YAC does not replicate exactly the deletion done in the context of the IlLCRe construct. Thus, a 61-bp 5' sequence has been deleted from the IlLCRe'construct but not from the~esil~-YAC (the 5' of the~-YAC deletion is at -406e, while the 5' of the IlLCR e deletion is at -467e). It is therefore possible that the 61-bp e promoter sequence COntains elements that are involved in e gene silencing, and these elements were left intact in the~esil~-YAC. This possibility cannot be excluded unless e gene expression is tested in~-YAC mice containing an e gene promoter deletion identical to that contained in the IlLCR::e gene construct. This interpretation also applies to the findings of a previous study in which 125 bp containing several motifs of the silencer were deleted from the e gene promoter in the Context of a 155-kb~-YAC (23). This deletion had no effect On e gene silencing in definitive erythropoiesis (23) . Second, there is evidence that not only the silencing element in the -467 to -182 region of the e gene promoter but also other elements located between -467 and -2025 of the e promoter Contribute in turning off the s gene in definitive erythropoiesis (20, 29) . Third, sequences of the proximal promoter are also involved in e gene silencing. Thus, when the CACCC box of the y gene is replaced by the e gene CACCC box, there is striking reduction of y gene expression in definitive erythropoiesis, suggesting that the e gene CACCC box Participates in gene silencing (30) . Filipe et al. (21) mutated two direct repeats located near the CAAT box in the proximal s-globin promoter and showed that these DR elements are required to silence s-globin gene expression dUring definitive erythropoiesis. Tanimoto et al. t (22) have further shown that mutation of the DR elements in the context of a 150-kb~-locus YAC resulted in a continued s-globin transcription during the definitive erythropoiesis of the fetal liver and adult spleen.
It is therefore likely that a large repressor complex or a multitude of cooperating small repressor complexes interacts with sequences of the upstream as well as the proximal promoter, resulting in e gene silencing in definitive erythropoiesis. It is also likely that this complex(es) silence e gene expression by disrupting the interaction between the s-globin gene and the LCR. We postulate that mutations affecting promoter sequences with which the putative complex interacts decrease the stability of the interaction between the LCR and the e gene promoter. In the context of the IlLCR::e transgenic constructs, the deletion of the -467 to -182 silencer or mutations of its motifs produce a phenotype because the postulated repression complex is incomplete, it binds weakly on the e promoter, and it cannot interrupt the interaction between the promoter and the LCR. Deletion of the silencer sequence in the context of the~ locus YAC results in an incomplete silencing complex that binds weakly in the e gene promoter; however, in the context of the~-locus YAC the deletion does not produce a phenotype because the environment of definitive erythropoiesis favors the interaction of the LCR with the down-stream~-globin gene. This competitive interaction of the LCR with the downstream adult~-globin gene compensates for the weak binding of the repressor complex when the e silencer is deleted.
As mentioned earlier, in a previous study, a 125-bp deletion from the a gene promoter containing sequences of the e gene silencer was done in the context of a 155-kb~ YAC. Paradoxically, a severe decline in y-globin mRNA was observed in the yolk sac in three transgenic mouse lines during embryonic erythropoiesis (23) . Two of the three transgenic lines also exhibited a reduction of y-and~ globin mRNA in the fetal erythropoiesis, and all three lines had reduction of~-globin gene expression in the erythroid cells residing in the adult spleen. However, characteristic of this study was striking variation in globin gene expression among lines (23) . This variation suggests that these transgenic mice have been subjected to strong position effects. The low levels of y and~gene expression most likely represents the result of integration of these transgenes at or near heterchromatic regions and suggest that the 155-kb~-YAC used in these studies, in contrast to the 213-kb -YAC, is more prone to be subjected to position effects by the surrounding murine chromatin.
